May 15, 2024 05:49AM
May 14, 2024 07:13PM
May 8, 2023 04:35PM
May 8, 2023 04:33PM
May 4, 2023 05:28AM
May 3, 2023 07:22PM
Apr 24, 2023 05:10PM Johnson & Johnson prices consumer spinoff Kenvue at $20-$23 a share in IPO
Apr 24, 2023 04:27PM
Oct 19, 2022 06:20PM
Nov 12, 2021 09:22AM
Mar 30, 2020 09:30AM
Oct 8, 2018 09:16AM
Apr 24, 2018 04:01PM
Sep 29, 2017 02:43PM Form F-6 POS Actelion Ltd/ADR Filed by: Deutsche Bank Trust Co Americas/ ADR Group
Apr 21, 2016 12:16PM
Oct 5, 2015 10:24AM
Sep 29, 2015 09:26AM
Sep 29, 2015 07:34AM
Sep 29, 2015 06:41AM
Apr 30, 2015 09:00AM
Dec 23, 2014 10:48AM Celgene (CELG), Related Stocks Decline Amid Biopharma Weakness
Oct 14, 2014 11:15AM
Sep 30, 2014 11:24AM
Apr 14, 2014 10:39AM
Jan 16, 2014 09:56AM
Nov 1, 2013 11:45AM
Sep 30, 2013 11:26AM
Jul 17, 2013 06:58AM Deutsche Bank Downgrades Johnson & Johnson (JNJ) to Hold on Valuation
Jul 16, 2013 09:21AM
Jan 22, 2013 10:25AM
Jan 4, 2013 11:06AM
Jan 4, 2013 07:27AM
Nov 7, 2012 09:01AM
Nov 6, 2012 10:56AM
Jun 4, 2012 11:33AM Deutsche Bank Defends Dendreon (DNDN) Despite Strong Zytiga Data; Maintains Buy
Jun 4, 2012 09:29AM
May 17, 2012 10:40AM
Mar 8, 2012 09:30AM
Oct 10, 2011 10:03AM
Oct 4, 2011 11:08AM
Jul 8, 2011 11:11AM
Jul 8, 2011 07:00AM Deutsche Bank Starts Johnson & Johnson (JNJ) at Hold; Some Upside But Mot Enough
Jun 16, 2011 08:18AM
Apr 8, 2011 01:52PM
Mar 18, 2011 10:32AM
Apr 26, 2010 03:00PM
Feb 11, 2010 07:32AM
Oct 12, 2009 07:14AM
Apr 20, 2009 09:34AM David Moenning's Daily State of the Markets: 4/20
Apr 14, 2009 09:42AM

55,975 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All